Intragastric Balloon Market Size to Reach USD 163.7 Billion by 2032 growing at 11.8% CAGR - Exclusive Report by Acumen Research and Consulting

Author: Acumen Research and Consulting

The Intragastric Balloon Market, valued at USD 54.4 Billion in 2022, is anticipated to surpass USD 163.7 Billion by 2032, reflecting a projected CAGR of 11.8%

The intragastric balloon industry has grown significantly in recent years, driven by rising worldwide obesity concerns and a need for minimally invasive weight loss treatments. Intragastric balloons are non-surgical devices that are put in the stomach to provide a sense of fullness, hence limiting food intake and facilitating weight loss. Factors driving market expansion include increased obesity rates, lifestyle changes, and the desire of less intrusive weight loss alternatives to standard surgical treatments. As people seek better and less dangerous weight control therapies, the demand for intragastric balloons has increased. The industry is characterized by continuous technical breakthroughs in balloon design and materials, which make these devices safer, more lasting, and more accepted by patients. Furthermore, greater awareness of the health hazards associated with obesity, as well as the efficacy of intragastric balloons as part of comprehensive weight management programs, help to drive market growth.

However, obstacles remain in terms of patient qualifying requirements, funding concerns, and the necessity for extensive lifestyle modifications to maintain weight loss after balloon removal. The market is also driven by regulatory concerns and current research aimed at improving the overall safety and efficacy of intragastric balloon treatments. Despite these obstacles, the intragastric balloon market is expected to increase further as it tackles a crucial health concern and offers a vital non-surgical option for people looking for weight reduction treatments. The industry is expected to experience more technological advancements, increasing market penetration, and broader acceptability among healthcare professionals and patients looking for effective obesity control options.

Intragastric Balloon Market Value

Intragastric Balloon Market Statistics

  • In 2022, the global intragastric balloon market achieved a revenue of USD 54.4 Billion
  • Demonstrating consistent growth, the intragastric balloon market is expected to experience a CAGR of 11.8% from 2023 to 2032
  • North America dominated the intragastric balloon sector in 2022, commanding a substantial 38% market share
  • The Asia-Pacific region is poised for promising growth, with an anticipated CAGR of 13% from 2023 to 2032
  • Among products, the orbera (single) intragastric balloon sub-segment led the market with around 68% share in 2022
  • In 2022, the hospital end-user segment in the intragastric balloon recorded revenue of US$ 19.5 billion
  • A notable intragastric balloon market trend is the increasing emphasis on the development of advanced, swallowable, and deflatable balloon technologies

Request for a sample of this premium research report@

Intragastric Balloon Market Dynamics

Increasing Prevalence of Obesity Globally Fuels the Intragastric Balloon Market Value

The rising incidence of obesity on a global scale is a major factor driving the intragastric balloon industry. Obesity has become a major public health problem, connected to a variety of chronic disorders including diabetes, cardiovascular disease, and several malignancies. As people become more aware of the health dangers connected with obesity, there is an increased need for effective weight control options. The intragastric balloon market meets this demand by offering a weight loss alternative that is both less invasive and reversible.

The rise in obesity rates, caused by factors such as sedentary lifestyles, bad eating habits, and genetic predispositions, has motivated many to seek help to reach and maintain a healthy weight. Intragastric balloons are a non-surgical method that generates a sense of fullness, allowing people to regulate their food intake and reduce weight. The market benefits from increased adoption of these devices by both patients and healthcare professionals, which contributes to the industry's overall growth. As the worldwide obesity epidemic continues, the intragastric balloon market is expected to grow as a key component of overall weight control efforts.

Ongoing Research for Improving the Efficacy and Safety of Balloons Offers Significant Intragastric Balloon Market Opportunity

The intragastric balloon industry offers tremendous prospects due to continuing research and development initiatives aimed at improving the efficacy and safety of balloon technology. Researchers and industry companies are actively investigating novel materials, designs, and deployment methods to enhance patient outcomes and broaden the market's reach. Continuous advances attempt to solve balloon-related difficulties such as patient tolerance, durability, and the requirement for long-term weight maintenance solutions.

The market opportunity is particularly visible in the quest of producing next-generation intragastric balloons with better qualities such as reduced risk of deflation or migration, increased patient comfort, and extended efficacy. Furthermore, researchers are looking into ways to improve the integration of intragastric balloons into complete weight reduction programs, combining lifestyle changes with behavioral support to achieve long-term effects. As these developments become available, they have the potential to increase the acceptance of intragastric balloons as a realistic and appealing alternative in the larger landscape of obesity management. The dedication to continuing research positions the intragastric balloon industry for long-term growth, providing creative solutions to suit the changing demands of people seeking effective and less invasive weight reduction treatments.

Intragastric Balloon Market Segmentation

The global market for intragastric balloon has been segmented into administration, product, filling material, end user, and region.

  • The administration segment is split into endoscopy and pill form
  • The products segment is categorized into orbera (single) intragastric balloon, reshape (dual) intragastric balloon, and obalon (triple) intragastric balloon
  • The filling material segment is categorized into saline filled and gas filled
  • End-users segment includes ambulatory surgical centers, hospitals, and clinics
  • The Intragastric Balloon market is geographically segmented across North America (NA), Europe (EU), Asia-Pacific (APAC), the Middle East and Africa (MEA), and Latin America (LA)

Intragastric Balloon Market Regional Outlook

The North American area, notably the United States, is a major market for intragastric balloons. The high incidence of obesity in the United States, along with a strong emphasis on health and wellbeing, has led to the use of intragastric balloons as a non-surgical weight loss strategy. The well-established healthcare infrastructure and advantageous reimbursement rules also contribute to market expansion.

Europe is a major market for intragastric balloons, with the United Kingdom, Germany, and France leading in terms of usage. The region benefits from rising awareness of the health problems associated with obesity, as well as a preference for least intrusive weight loss methods. Favorable reimbursement conditions in several European nations help to drive industry growth.

Obesity rates are growing in the Asia-Pacific region, notably in China and India, fuelling need for effective weight management strategies. The market is also driven by an expanding middle class and rising healthcare costs. However, factors such as cultural attitudes toward weight control and regulatory landscapes may influence market dynamics throughout the area.

Intragastric Balloon Market Players

Intragastric Balloon companies profiled in the report include Allurion Technologies Inc., Apollo Endosurgery, Inc, Helioscopie Medical Implants, Districlass Medical, Silimed, Medsil, Lexel S.R.L, Obalon Therapeutics, Spatz3, ReShape Lifesciences, Endalis, and Spatz3.

Click here to buy the Premium Market Research report

Receive our personalized services and customization by clicking here

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533